2020.Nov.23
未分類
Corporate
ESMO Asia 2020 Virtual Annual Meeting for OBI-833, a Novel Anti-Globo H Targeted Therapeutic Cancer Vaccine
1. Presentation number: 397P / Poster: ID 680 Title: A phase I cohort expansion trial of OBI-833 in non-small cell lung cancer patients Presenter: Ching-Liang Ho MD, et.al. Department of Internal Medicine, Tri-Service General Hospital, Taipei, Taiwan. Session Title: E-poster Display session – Thoracic tumors, metastatic Session Date and Time: Friday, November 20, 2020. 9:00 […]
This article is password protected.
To view the content, please enter your password in the field below